Table 1.
Clinical characteristics of cirrhotic patients with and without hepatocellular carcinoma (HCC)
| Group I | Group II | p-value* | |
|---|---|---|---|
| (Cirrhosis) | (Cirrhosis and HCC) | ||
| N (%) | 45 (50.0 %) | 45 (50.0 %) | |
| Age | 58.68 ± 10.76 | 64.64 ± 7.73 | 0.003 |
| Sex (F/M) | (1/49) | (0/50) | |
| Child-Pugh class | 0.052 | ||
| A | 20 (44.4 %) | 21 (45.6 %) | |
| B | 8 (17.8 %) | 16 (35.6 %) | |
| C | 17 (37.8 %) | 8 (17.8 %) | |
| MELD scorea | 14.04 ± 5.56 | 12.71 ± 4.25 | 0.205 |
| BCLC Stageb | |||
| 0 | 2 (4.4 %) | ||
| A | 19 (42.2 %) | ||
| B | 11 (24.4 %) | ||
| C | 7 (15.6 %) | ||
| D | 6 (13.3 %) |
*p - Value was calculated by using Student T test or χ2 test
aModel for End-stage Liver Disease score
bBarcelona Clinic Liver Cancer